IR-Med (IRME) has provided an announcement.
Aharon Klein, a seasoned medical device and biotech expert with a strong clinical background, has been appointed as the Interim Chief Executive Officer of IR-Med, Inc. and its subsidiary, IR-Med LTD. With a history of founding and leading innovative medical start-ups, including a company that developed non-invasive diagnostic tools for colon cancer, Klein’s expertise is set to guide IR-Med through its next phase. His appointment is a strategic move, leveraging his extensive experience in the industry and previous leadership roles within the company.
Find detailed analytics on IRME stock on TipRanks’ Stock Analysis page.